[go: up one dir, main page]

SK40097A3 - A process for the quantitative synthesis of 3-(l-pyroglutamyl)-l- -thiazolidine-4-carboxylic acid and derivatives thereof - Google Patents

A process for the quantitative synthesis of 3-(l-pyroglutamyl)-l- -thiazolidine-4-carboxylic acid and derivatives thereof Download PDF

Info

Publication number
SK40097A3
SK40097A3 SK400-97A SK40097A SK40097A3 SK 40097 A3 SK40097 A3 SK 40097A3 SK 40097 A SK40097 A SK 40097A SK 40097 A3 SK40097 A3 SK 40097A3
Authority
SK
Slovakia
Prior art keywords
halide
compound
formula
thiazolidine
carboxylic acid
Prior art date
Application number
SK400-97A
Other languages
Slovak (sk)
Inventor
Stefano Poli
Ambrogio Magni
Gianettore Bocchiola
Original Assignee
Poli Ind Chimica Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Poli Ind Chimica Spa filed Critical Poli Ind Chimica Spa
Publication of SK40097A3 publication Critical patent/SK40097A3/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06139Dipeptides with the first amino acid being heterocyclic
    • C07K5/06173Dipeptides with the first amino acid being heterocyclic and Glp-amino acid; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Catalysts (AREA)
  • Pyrrole Compounds (AREA)

Abstract

3-(L-Pyroglutamyl)-L-thiazolidine-4-carboxylic acid and the derivatives thereof are prepared in quantitative yields by a condensation process between L-pyroglutamic acid or substitution products thereof in the presence of an aliphatic or aromatic hydrocarbon solvent, or of chlorinated solvents in the presence of dicyclohexylcarbodiimide or similar condensing agents, or by condensation of L-pyroglutamic acid reactive derivatives with thiazolidine-4-carboxylic acid derivatives. The hydrolysis of the protective groups of thiazolidine-4-carboxylic acid is carried out by phase transfer catalysts in quantitative yields.

Description

Spôsob výroby kyseliny 3-(L-pyroglutamyl)-L-tiazolidín-4karboxylovej a jej derivátovProcess for the preparation of 3- (L-pyroglutamyl) -L-thiazolidine-4-carboxylic acid and its derivatives

Oblasť technikyTechnical field

Predkladaný vynález sa týka postupu prípravy kyseliny L-pyroglutámovej alebo jej derivátov.The present invention relates to a process for the preparation of L-pyroglutamic acid or derivatives thereof.

Doterajší stav technikyBACKGROUND OF THE INVENTION

Taliansky patent č. 1 202 426 opisuje kyselinu 3-(L-pyroglutamyl)-L-tiazolidín-4-karboxylovú, ktorá má imunostimulačné, antitoxické, protizápalové, antioxidačné vlastnosti a vlastnosti spomaľovania stárnutia a pripravuje sa z reaktívneho esteru kyseliny L-pyroglutámovej alebo z jej chloridu a z kyseliny L-tiazolidín-4-karboxylpvej.Italian patent no. No. 1,202,426 discloses 3- (L-pyroglutamyl) -L-thiazolidine-4-carboxylic acid having immunostimulatory, antitoxic, anti-inflammatory, antioxidant and aging retarding properties and is prepared from a reactive ester of L-pyroglutamic acid or its chloride and from L-thiazolidine-4-carboxylic acid.

V postupe sú použité najmä napríklad reaktívne estery kyseliny L-glutámovej s pentachlorfenolom, pentafluorfenolom, 2,4,5-trichlorfenolom, N-hydr.oxysukcínimidom, N-hydroxyftalimidom, ktoré reagujú s kyselinou L-tiazolidín-4-karboxylovou v aprotických rozpúšťadlách za prítomnosti terciárnych báz, alebo chloridu kyseliny L-pyroglutámovej, ktorý reaguje s kyselinou L-tiazolidín-4-karboxylovou v alkalickom médiu.In particular, the reactive esters of L-glutamic acid with pentachlorophenol, pentafluorophenol, 2,4,5-trichlorophenol, N-hydrosuccinimide, N-hydroxyphthalimide, which react with L-thiazolidine-4-carboxylic acid in aprotic solvents, are used in the process. the presence of tertiary bases, or L-pyroglutamic acid chloride, which reacts with L-thiazolidine-4-carboxylic acid in an alkaline medium.

Taliansky patent č. 1 230 706 opisoval deriváty kyseliny 3-(L-pyroglutamyl)-L-tiazolidín-4-karboxylovej, ktoré majú rovnaké farmakologické účinky a ktoré sa pripravujú podobnými postupmi z reaktívnych esterov alebo amidov kyseliny L-pyroglutamyl-tiazolidín-4-karboxylovej a alkoholov alebo amínov.Italian patent no. No. 1,230,706 described 3- (L-pyroglutamyl) -L-thiazolidine-4-carboxylic acid derivatives having the same pharmacological effects and prepared by similar procedures from L-pyroglutamyl-thiazolidine-4-carboxylic acid reactive esters or amides and alcohols or amines.

Z praktického hľadiska majú tieto postupy niektoré nedostatky, menovite: obtiažne postupy s extrémne nízkymi celkovými výťažkami, použitie látok vysoko toxických pre človeka a životné prostredie, ako sú napríklad halogenované fenoly, použitie L-pyroglutamylchloridu, ktorý sa ťažko pripravuje a s ktorým sa ťažko pracuje, ako aj slabá stabilita reaktívnych esterov kyseliny L-pyroglutamovej s N-hydroxysuk2 cínimidom a N-hydroxyftalimidom.In practice, these processes have some drawbacks, namely: difficult processes with extremely low overall yields, the use of highly toxic to humans and the environment, such as halogenated phenols, the use of L-pyroglutamyl chloride, which is difficult to prepare and difficult to handle, as well as poor stability of the reactive esters of L-pyroglutamic acid with N-hydroxysuccinimide and N-hydroxyphthalimide.

Taliansky patent č. 1 239 029 opisuje postup, kde sa vyššie spomenuté problémy čiastočne vyriešili pomocou jednoduchšieho postupu, bez použitia zvlášť toxických látok, náročných a/alebo nestabilných medziproduktov a s vyššími výťažkami. Takýto postup sa prejavil prekvapujúcou stabilitou etyltiazolidín-4-karboxylátu za získania podstatne vyšších výťažkov ako v prípade použitia iných jednoduchých esterov, ako napríklad metyl- a izopropylesterov.Italian patent no. No. 1,239,029 discloses a process wherein the above-mentioned problems have been partially solved by a simpler process, without the use of particularly toxic substances, demanding and / or unstable intermediates, and with higher yields. Such a process has shown the surprising stability of ethylthiazolidine-4-carboxylate to yield substantially higher yields than other simple esters such as methyl and isopropyl esters.

Teraz sa zistilo, že uvedený postup možno ďalej zdokonaľovať, aby sa získali takmer kvantitatívne výťažky požadovaných produktov, pomocou kondenzácie etyltiazolidín-4-karboxylátu alebo jeho derivátu s derivátom kyseliny L-pyroglutámovej v apolárnych aprotických rozpúšťadlách a konečne hydrolýzou etylesteru v podmienkach fázového prenosu.It has now been found that the process can be further improved to obtain almost quantitative yields of the desired products, by condensing ethylthiazolidine-4-carboxylate or a derivative thereof with an L-pyroglutamic acid derivative in apolar aprotic solvents and finally hydrolyzing the ethyl ester under phase transfer conditions.

Podstata vynálezuSUMMARY OF THE INVENTION

Preto vynález poskytuje spôsob prípravy zlúčeniny vzorca III,Therefore, the invention provides a process for the preparation of a compound of formula III,

kde R·*· je H, C^-Cgalkyl, -Cycykloalkyl, C^-C^Qcykloalkylalkyl, aryl a substituovaný aryl, C2-C5alkoxykarbonyl, C2“CiQalkylkarbonyl, arylkarbonyl a aralkylkarbonyl, Cg-C^garalkoxykarbonyl, substituovaný aralkoxykarbonyl, ktorý zahrnuj e:wherein R 6 is H, C 1 -C 6 alkyl, -Cycycloalkyl, C 1 -C 6 cycloalkylalkyl, aryl and substituted aryl, C 2 -C 5 alkoxycarbonyl, C 2 -C 6 alkylcarbonyl, arylcarbonyl and aralkylcarbonyl, C 6 -C 6 garalkoxycarbonyl, substituted aralkoxycarbonyl, includes:

a) reakciu zlúčeniny vzorca I ,a) reaction of a compound of formula I,

(I) kde R1 je, ako už bolo definované a X je OH, Cl alebo OR2, kde R2 je aktivujúca skupina, so zlúčeninou vzorca II,(I) wherein R 1 is as defined above and X is OH, Cl or OR 2 , wherein R 2 is an activating group, with a compound of formula II,

kde je H, C3-Cgtrialkylsilyl, v apolárnych aprotických rozpúšťadlách;wherein H is C 3 -C 8trialkylsilyl, in apolar aprotic solvents;

b) zásaditú hydrolýzu etylesteru získaného v kroku a) za podmienok fázového prenosu.b) basic hydrolysis of the ethyl ester obtained in step a) under phase transfer conditions.

Apolárne aprotické rozpúšťadlá sú vybrané najmä z n-pentánu, n-hexánu, n-heptánu, n-oktánu, izooktánu, nonánu, dekánu, petroléteru, ligroínu, toluénu, xylénu, kuménu, dichlormetánu, chloroformu, dichloretánu a ich zmesí. Ak sa použije zlúčenina vzorca I, kde X = OH, reakcia so zlúčeninou vzorca II sa uskutočňuje v prítomnosti kondenzačného činidla, ako napríklad dicyklohexylkarbodiimidu alebo diizopropylkarbodiimidu.The apolar aprotic solvents are particularly selected from n-pentane, n-hexane, n-heptane, n-octane, isooctane, nonane, decane, petroleum ether, ligroin, toluene, xylene, cumene, dichloromethane, chloroform, dichloroethane and mixtures thereof. When a compound of formula I wherein X = OH is used, the reaction with the compound of formula II is carried out in the presence of a condensing agent such as dicyclohexylcarbodiimide or diisopropylcarbodiimide.

Etylester získaný v kroku a) je transformovaný do zodpovedajúcej kyseliny, v kvantitatívnom výťažku, v podmienkach miernej hydrolýzy pomocou katalyzátorov fázového prenosu v zásaditom médiu.The ethyl ester obtained in step a) is transformed into the corresponding acid, in quantitative yield, under conditions of moderate hydrolysis by phase transfer catalysts in a basic medium.

V tomto kroku sa používajú katalyzátory ako tetrabutylamóniumhalogenid alebo hydrogénsíran alebo tetrafluórborát, tetraetylamóniumhalogenid alebo hydrogénsíran alebo tetrafluorborát; cetypyrdíniumhalogenid, metyltributyhalogenid, Adogen 464, trimetycetylamónium-p-toluéňsulfonát, tetrabutylfosfóniumhalogenid, tetrafenylfosfóniumhalogenid, trifenylmetylfosfóniumhalogenid, butylpyridíniumhalogenid.Catalysts such as tetrabutylammonium halide or hydrogen sulphate or tetrafluoroborate, tetraethylammonium halide or hydrogen sulphate or tetrafluoroborate are used in this step; cetypyridinium halide, methyltributyl halide, Adogen 464, trimethylacetyl ammonium p-toluenesulfonate, tetrabutylphosphonium halide, tetrafenylphosphonium halide, triphenylmethylphosphonium halide, butylpyridinium halide.

Za týchto podmienok, za použitia derivátov kyseliny tiazolidín-4-karboxylovej esterifikovaných metanolom, propanolom alebo izopropanolom sa získajú výrazne nižšie výťažky. Nasledovné príklady sú použité na ilustráciu predkladaného vynálezu.Under these conditions, significantly lower yields are obtained using thiazolidine-4-carboxylic acid derivatives esterified with methanol, propanol or isopropanol. The following examples are used to illustrate the present invention.

Príklady uskutočnenia vynálezuDETAILED DESCRIPTION OF THE INVENTION

Príklad 1Example 1

16,78 g etyl L-tiazolidín-4-karboxylát hydrochloridu (0,084 molu) sa suspeiiduje v 160 ml toluénu, pridá sa 7,06 g hydrogénuhličitanu sodného (0,085 molov), zohrieva sa do refluxu za miešania 5 hodín, azeotrópne sa odstráni voda. Zmes sa ochladí na 0 až 5 ‘C, pridá sa 12 g kyseliny L-pyroglutámovej (0,093 molov), potom sa po kvapkách pridá roztok 19,2 g dicyklohexylkarbodiimidu v 20 ml toluénu. Po 1 hodine pri 0 °C sa teplota zvýši na 20 až 25 °C na ďalších 12 hodín, potom sa odfiltruje dicyklohexylmočovina.16.78 g of ethyl L-thiazolidine-4-carboxylate hydrochloride (0.084 mol) are suspended in 160 ml of toluene, 7.06 g of sodium bicarbonate (0.085 mol) are added, heated to reflux with stirring for 5 hours, water is azeotropically removed . The mixture is cooled to 0-5 ° C, 12 g of L-pyroglutamic acid (0.093 moles) are added, then a solution of 19.2 g of dicyclohexylcarbodiimide in 20 ml of toluene is added dropwise. After 1 hour at 0 ° C the temperature is raised to 20-25 ° C for an additional 12 hours, then the dicyclohexylurea is filtered off.

Prefiltrovaný roztok sa doplní 20 ml vody, pridá sa 0,64 g tetrabutylamóniumhydrogénsulfátu (0,0042 molov), ochladí sa na 0 až 5 °C, potom sa pridá roztok 3,36 g hydroxidu sodného (0,084 molov) v 20 ml vody. Po miešaní 30 minút sa odseparuje vodná fáza, okyslí sa na pH 1 kyselinou chlorovodíkovou, po 2 hodinách sa roztok prefiltruje, premyje sa vodou a vysuší sa, aby sa získalo 19,5 g (96 %) kyselinyThe filtered solution is made up to 20 ml with water, 0.64 g of tetrabutylammonium hydrogen sulphate (0.0042 moles) is added, cooled to 0-5 ° C, then a solution of 3.36 g of sodium hydroxide (0.084 moles) in 20 ml of water is added. After stirring for 30 minutes, the aqueous phase is separated, acidified to pH 1 with hydrochloric acid, after 2 hours the solution is filtered, washed with water and dried to give 19.5 g (96%) of the acid.

3-(L-pyroglutamyl)-L-tiazolidín-4-karboxylovej, t.t. 193 až 194 ’C.3- (L-pyroglutamyl) -L-thiazolidine-4-carboxylic acid, m.p. 193 to 194 ’C.

Príklad 2Example 2

Postup prebieha ako v príklade 1, toluén je nahradený dichlormetánom, aby sa získalo 19,2 g (95 %) kyseliny 3-(Lpyroglutamyl)-L-tiazolidín-4-karboxylovej, t.t. 193 až 194 ’C.Operating as in Example 1, toluene is replaced with dichloromethane to give 19.2 g (95%) of 3- (Lpyroglutamyl) -L-thiazolidine-4-carboxylic acid, m.p. 193 to 194 ’C.

Príklad 3Example 3

Postup prebieha ako v príklade 1, toluén je nahradený N-hexánom, aby sa získalo 19,1 g (94 %) kyseliny 3-(L-pyroglutamyl) -L-tiazolidín-4-karboxylovej , t.t. 193 až 194 ’C.Operating as in Example 1, toluene is replaced with N-hexane to give 19.1 g (94%) of 3- (L-pyroglutamyl) -L-thiazolidine-4-carboxylic acid, m.p. 193 to 194 ’C.

Príklad 4 g kyseliny L-N-t-butoxykarbonylpyroglutámovej a 16,1 g etyl-L-tiazolidín-4-karboxylátu sa rozpustí v 150 ml dichlórmetánu, ochladí sa na 0,5 °C, potom sa pridá 21 g dicyklohexylkarbodiimidu (0,105 molov) a mieša sa 15 hodín pri uvedenej teplote.Example 4 g of LNt-butoxycarbonylpyroglutamic acid and 16.1 g of ethyl L-thiazolidine-4-carboxylate are dissolved in 150 ml of dichloromethane, cooled to 0.5 ° C, then 21 g of dicyclohexylcarbodiimide (0.105 moles) are added and stirred 15 hours at the indicated temperature.

Dicyklohexylmočovina sa odfiltruje, potom sa filtrát doplní 50 ml vody, 0,75 g tetrabutylamóniumhydrogénsulfátu (0,005 molov). Zmes sa ochladí na 0 až 5 °C, potom sa roztok 6,6 g hydroxydu draselného (0,1 molu) v 30 ml vody pridá k zmesi, mieša sa pri tejto teplote 30 minút, potom sa obe fázy odseparujú. Vodná fáza sa okyslí na pH 1 koncentrovanou kyselinou chlorovodíkovou. Precipitovaná tuhá látka sa odfiltruje, premyje vodou a vysuší. Získa sa 21,3 g kyseliny 3-(L-pyroglutamyl)-L-tiazolidín-4-karboxylovej, t.t. 193 až 194 “C, výťažok 88 %.The dicyclohexylurea is filtered off, then the filtrate is made up with 50 ml of water, 0.75 g of tetrabutylammonium hydrogen sulfate (0.005 mol). The mixture is cooled to 0-5 ° C, then a solution of 6.6 g of potassium hydroxide (0.1 mol) in 30 ml of water is added to the mixture, stirred at this temperature for 30 minutes, then the two phases are separated. The aqueous phase is acidified to pH 1 with concentrated hydrochloric acid. The precipitated solid is filtered off, washed with water and dried. 21.3 g of 3- (L-pyroglutamyl) -L-thiazolidine-4-carboxylic acid are obtained, m.p. 193-194 ° C, yield 88%.

Nasledovná tabuľka vyjadruje výsledky získané za použitia esterov kyseliny L-tiazolidín-4-karboxylovej; v prípade tejto patentovej žiadosti ide o etylester, ktorý reagoval za tých istých podmienok, ako bolo uvedené vo vyššie spomenutých príkladoch.The following table shows the results obtained using L-thiazolidine-4-carboxylic acid esters; this patent application is an ethyl ester which reacted under the same conditions as those described in the above examples.

Tabuľkatable

Ester ester Príklad Example Výťažok yield Príklad Example Výťažok yield metyl methyl 1 1 53 53 2 2 33 33 n-propyl n-propyl 1 1 48 48 2 2 41 41 i-propyl i-propyl 1 1 61 61 2 2 54 54

Claims (9)

PATENTOVÉ NÁROKYPATENT CLAIMS 1. Spôsob výroby zlúčeniny vzorca III, kdeA process for producing a compound of formula III, wherein R1 je H, C^-Cgalkyl, Cg-C^cykloalkyl, C^-C-^Qcykloalkylalkyl, aryl a substituovaný aryl, C2-Cgalkoxykarbonyl, Cg-C^aralkoxykarbonyl, arylkarbonyl a aralkylkarbonyl, substituovaný aralkoxykarbonyl, vyznačujúci sa tým, že zahrňuj e:R 1 is H, C 1 -C 6 alkyl, C 1 -C 6 cycloalkyl, C 1 -C 6 cycloalkylalkyl, aryl and substituted aryl, C 2 -C 6 alkoxycarbonyl, C 8 -C 6 aralkoxycarbonyl, arylcarbonyl and aralkylcarbonyl, substituted aralkoxycarbonyl, that includes: a) reakciu zlúčeniny vzorca I,a) reaction of a compound of formula I, 1 2. kde R je, ako už bolo definované a X je OH, Cl alebo OR , kde R je aktivujúcu skupina, so zlúčeninou vzorca II, (II)Wherein R is as defined above and X is OH, Cl or OR, wherein R is an activating group, with a compound of Formula II, (II) COOCjHg qCOOCjHg q kde R je H, C^-Cgtrialkylsilyl, v apolárnych aprotických rozpúšťadlách;wherein R is H, C1-C6trialkylsilyl, in apolar aprotic solvents; b) zásaditú hydrolýzu etylesteru získaného v kroku a) za podmienok fázového prenosu.b) basic hydrolysis of the ethyl ester obtained in step a) under phase transfer conditions. 2. Spôsob podľa nároku 1, vyznačujúci saMethod according to claim 1, characterized by Ί tým, že apolárne aprotické rozpúšťadlá sú vybrané z n-pentánu, n-hexánu, n-heptánu, n-oktánu, izooktánu, nonánu, dekánu, petroléteru, ligroínu, toluénu, xylénu, kuménu, dichlormetánu, chloroformu, dichloretánu a ich zmesí.Ί in that the apolar aprotic solvents are selected from n-pentane, n-hexane, n-heptane, n-octane, isooctane, nonane, decane, petroleum ether, ligroin, toluene, xylene, cumene, dichloromethane, chloroform, dichloroethane and mixtures thereof . 3. Spôsob podľa nároku 1, vyznačujúci sa tým, že X je OH a krok a) je uskutočnený v prítomnosti kondenzačného činidla vybraného z dicyklohexylkarbodiimidu a diizopropylkarbodiimidu.The method of claim 1, wherein X is OH and step a) is carried out in the presence of a condensing agent selected from dicyclohexylcarbodiimide and diisopropylcarbodiimide. 4. Spôsob podľa nároku 1, vyznačujúci sa tým, že katalyzátory fázového prenosu sú vybrané z tetrabutylamóniumhalogenidu alebo hydrogénsíranu alebo tetrafluorborátu, tetraetylamóniumhalogenidu alebo hydrogénsíranu alebo tetrafluorborátu; cetylpyridíniumhalogenidu, metyltributylhalogenidu, Adogenu 464, trimetylcetylamónium-p-toluénsulfonátu, tetrabutylfosfóniumhalogenidu, tetrafenylfosfóniumhalogenidu, trifenylmetylfosfóniumhalogenidu, butylpyridíniumhalogenidu.The process of claim 1, wherein the phase transfer catalysts are selected from tetrabutylammonium halide or hydrogen sulphate or tetrafluoroborate, tetraethylammonium halide or hydrogen sulphate or tetrafluoroborate; cetylpyridinium halide, methyltributyl halide, Adogen 464, trimethylcetylammonium p-toluenesulfonate, tetrabutylphosphonium halide, tetrafenylphosphonium halide, triphenylmethylphosphonium halide, butylpyridinium halide. 5. Spôsob podľa nároku 1, vyznačujúci sa tým, že R·*· je vybraný z vodíka a C2“C3alkoxykarbonylu.The process of claim 1, wherein R 6 is selected from hydrogen and C 2 -C 3 alkoxycarbonyl. 6. Spôsob podľa nároku 1, vyznačujúci sa tým, že zlúčeninou vzorca I je kyselina L-pyroglutámová.The process of claim 1 wherein the compound of formula I is L-pyroglutamic acid. 7. Spôsob podľa nároku 1, vyznačujúci sa tým, že zlúčeninou vzorca I je kyselina L-N-t-butoxykarbonylpyroglutámová.A process according to claim 1 wherein the compound of formula I is L-N-t-butoxycarbonylpyroglutamic acid. 8. Spôsob podľa ktoréhokoľvek z predchádzajúcich nárokov na prípravu kyseliny 3-(L-pyroglutamyl)-L-tiazolidín-4karboxylovej.Process according to any one of the preceding claims for the preparation of 3- (L-pyroglutamyl) -L-thiazolidine-4-carboxylic acid. 9. Spôsob podľa nároku 8, vyznačujúci sa tým, že zlúčenina vzorca I, kde R1 je vodík a X je OH, reaguje so zlúčeninou vzorca II, kde R je vodík.The process according to claim 8, wherein the compound of formula I wherein R 1 is hydrogen and X is OH is reacted with a compound of formula II wherein R is hydrogen.
SK400-97A 1994-09-27 1995-09-21 A process for the quantitative synthesis of 3-(l-pyroglutamyl)-l- -thiazolidine-4-carboxylic acid and derivatives thereof SK40097A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITMI941955A IT1270017B (en) 1994-09-27 1994-09-27 "QUANTITATIVE SYNTHESIS OF 3- (L-PIROGLUTAMIL) -L-THIAZOLIDIN-4- CARBOXYLIC ACID AND ITS DERIVATIVES"
PCT/EP1995/003720 WO1996010036A1 (en) 1994-09-27 1995-09-21 A process for the quantitative synthesis of 3-(l-pyroglutamyl)-l-thiazolidine-4-carboxylic acid and derivatives thereof

Publications (1)

Publication Number Publication Date
SK40097A3 true SK40097A3 (en) 1997-09-10

Family

ID=11369599

Family Applications (1)

Application Number Title Priority Date Filing Date
SK400-97A SK40097A3 (en) 1994-09-27 1995-09-21 A process for the quantitative synthesis of 3-(l-pyroglutamyl)-l- -thiazolidine-4-carboxylic acid and derivatives thereof

Country Status (10)

Country Link
CN (1) CN1143863C (en)
BG (1) BG63895B1 (en)
BR (1) BR9509087A (en)
CO (1) CO4480030A1 (en)
CZ (1) CZ91597A3 (en)
IT (1) IT1270017B (en)
PL (1) PL181824B1 (en)
RO (1) RO115957B1 (en)
SK (1) SK40097A3 (en)
WO (1) WO1996010036A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108088936B (en) * 2017-12-08 2020-05-22 常州寅盛药业有限公司 Impurity obtained in preparation of pidotimod ethyl ester and quality detection method thereof
CN108715598A (en) * 2018-06-13 2018-10-30 峨眉山宏昇药业股份有限公司 A kind of preparation method of Pidotimod
CN117088939A (en) * 2022-05-11 2023-11-21 江苏吴中医药集团有限公司 A kind of preparation method of Pidotimod

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1202426B (en) * 1987-01-26 1989-02-09 Poli Ind Chimica Spa THIAZOLIDIN-4-CARBOXYLIC ACID DERIVATIVE, ITS PREPARATION AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN IT
IT1239029B (en) * 1989-10-12 1993-09-20 Poli Ind Chimica Spa PROCESS FOR THE PREPARATION OF 3- (L-PYROGLUTAMYL) -L- THIAZOLIDIN-4-CARBOXYLIC ACID AND ITS DERIVATIVES.

Also Published As

Publication number Publication date
PL181824B1 (en) 2001-09-28
WO1996010036A1 (en) 1996-04-04
BR9509087A (en) 1998-07-21
CN1143863C (en) 2004-03-31
BG101310A (en) 1997-12-30
CZ91597A3 (en) 1997-09-17
ITMI941955A0 (en) 1994-09-27
PL319380A1 (en) 1997-08-04
RO115957B1 (en) 2000-08-30
IT1270017B (en) 1997-04-16
BG63895B1 (en) 2003-05-30
CO4480030A1 (en) 1997-07-09
CN1158620A (en) 1997-09-03
ITMI941955A1 (en) 1996-03-27

Similar Documents

Publication Publication Date Title
FI72719C (en) SYNTESFOERFARANDE FOER PIROXIKAM SAMT MELLANPRODUKT.
FI95271C (en) Process for preparing 3- (L-pyroglutamyl) -L-thiazolidine-4-carboxylic acid and its N-substituted derivatives
NZ234934A (en) Dihydrobenzofuran derivatives; medicaments
US5545654A (en) Pleuromutilin derivatives
EP0080229B1 (en) Salicylic derivatives of n-acetylcysteine
SK40097A3 (en) A process for the quantitative synthesis of 3-(l-pyroglutamyl)-l- -thiazolidine-4-carboxylic acid and derivatives thereof
US4125625A (en) Troponyl-oxamic acid derivatives
JPH03291267A (en) Preparation of substituted notroguanidines
ZA200502694B (en) Aplha-phenyl acetanilide derivatives having an acat inhibiting activity and therapeutic application thereof.
US4152456A (en) Tropone derivatives
US4886908A (en) Method of preparing (R)-4-amino-3-hydroxybutyric acid
Rosen et al. The Synthesis of Spin Labeled Acetylcholine Analogs
US4183955A (en) Troponyl-oxamic acid derivatives for treating allergic conditions
JP2000503666A (en) Camptothecin isolated from Mappia foetida-backbone compounds and their use as synthons for novel pharmaceutical and therapeutic agents
JPH05221941A (en) Carboxylic acid ester protecting group, formation thereof,coupling to functional group thereof and use thereof
MC1195A1 (en) ACYLUS DERIVATIVES
CN1035005C (en) A new method for preparing 6-(3-dimethylaminopropionyl)forskolin
Lal et al. In search of novel water soluble forskolin analogues for positive inotropic activity
FI79298B (en) NOW FOERFARANDE FOER FRAMSTAELLNING AV GLUTAMYLTAURIN.
WO1993018059A2 (en) L-thiazolidine-4-carboxylic acid derivative, processes for the preparation thereof and the use thereof in therapy
SU527134A3 (en) Method for preparing benzylamine derivatives or their salts
KR950009316B1 (en) Process for preparing pyrrolidinecarboxylic acid derivative
PT97320B (en) PROCESS FOR THE PREPARATION OF ACID DERIVATIVES 6-FLUOR-1,4-DIHYDRO-4-OXO-7-PIPERAZINYL-KINOLINOCARBOXYL ACID
MC1104A1 (en) NEW N-ALKANOL SUBSTITUTED HETEROCYCLIC AMINES, THEIR DERIVATIVES, THEIR METHODS OF PREPARATION